In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Philips Homes In on Respironics: Fills Gaps in Care Continuum

Executive Summary

No company has done more to wrap its arms around the whole area of patient monitoring--both in and out of the hospital--than Philips Medical Systems. Since early 2006, Philips has made at least seven acquisitions that have helped it create the infrastructure for a telehealth approach to disease management, including monitoring equipment, IT, and emergency response services. To close out 2007, Philips announced an additional acquisition: a $5.1 billion all-cash offer for respiratory therapy provider Respironics, to buy the leading company in a universe of only three independent companies focused on obstructive sleep apnea, the fastest growing market in home health monitoring.
Advertisement

Related Content

Wireless Health: Personalized Medicine Comes to the Device Industry
Health Care Trends: The Future of Remote Monitoring
Advanced Patient Monitoring Systems
Device Financings: Recent Growth, Future Opportunities
Medical Device and In Vitro Diagnostics Deal Statistics Quarterly, Q4 2007
Sleep Apnea: Medtech's High-Growth Sleeper
Trends for the New Year: Can Medtech Build on the Success of 2007?
Remote Patient Monitoring: The Markets Near and Far
Sleep Apnea: The Market Behind the Mask
The Shifting Sands of Sleep Apnea

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003023

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel